Managing a chronic illness can feel like a full-time job. Between juggling multiple appointments with an array of specialists and following a meticulous care plan, patients dealing with conditions like diabetes have a lot on their plate.
Medtech titan Medtronic (NYSE:MDT) wants to help change that. The company’s CEO, Omar Ishrak, placed his faith in value-based care as the future of healthcare. And Medtronic points to its work with Diabeter, a chain of diabetes clinics in the Netherlands that it acquired in 2015, as evidence of its progress towards delivering more value for patients.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic thinks these clinics could be the future of diabetes care – here’s why appeared first on MassDevice.
from MassDevice http://ift.tt/2FB25wH
Cap comentari:
Publica un comentari a l'entrada